CHRONIC HYPOPARATHYROIDISM

Clinical trials for CHRONIC HYPOPARATHYROIDISM explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HYPOPARATHYROIDISM trials appear

Sign up with your email to follow new studies for CHRONIC HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1 Completed 1

New injection aims to free patients from daily supplement dependence

Disease control Ongoing

This study is testing whether a new injectable drug called eneboparatide can help adults with chronic hypoparathyroidism. For the first 24 weeks, some participants will receive the drug while others get a placebo, and neither they nor their doctors will know which. The main goal …

Matched conditions: CHRONIC HYPOPARATHYROIDISM

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

CHRONIC HYPOPARATHYROIDISM

Get alerted when new CHRONIC HYPOPARATHYROIDISM trials appear

New injection aims to free patients from daily supplement dependence